Page last updated: 2024-10-24

candesartan cilexetil and Cardiac Output, Low

candesartan cilexetil has been researched along with Cardiac Output, Low in 1 studies

candesartan cilexetil: a prodrug which is metabolized to an active form candesartan to exert its biological effects

Cardiac Output, Low: A state of subnormal or depressed cardiac output at rest or during stress. It is a characteristic of CARDIOVASCULAR DISEASES, including congenital, valvular, rheumatic, hypertensive, coronary, and cardiomyopathic. The serious form of low cardiac output is characterized by marked reduction in STROKE VOLUME, and systemic vasoconstriction resulting in cold, pale, and sometimes cyanotic extremities.

Research Excerpts

ExcerptRelevanceReference
"A Medline literature search was undertaken to identify randomised, controlled trials that examined the efficacy and cardiovascular outcomes associated with candesartan cilexetil in hypertension and chronic heart failure (CHF)."8.84Candesartan cilexetil--a review of effects on cardiovascular complications in hypertension and chronic heart failure. ( Meredith, PA, 2007)
"A Medline literature search was undertaken to identify randomised, controlled trials that examined the efficacy and cardiovascular outcomes associated with candesartan cilexetil in hypertension and chronic heart failure (CHF)."4.84Candesartan cilexetil--a review of effects on cardiovascular complications in hypertension and chronic heart failure. ( Meredith, PA, 2007)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Meredith, PA1

Reviews

1 review available for candesartan cilexetil and Cardiac Output, Low

ArticleYear
Candesartan cilexetil--a review of effects on cardiovascular complications in hypertension and chronic heart failure.
    Current medical research and opinion, 2007, Volume: 23, Issue:7

    Topics: Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds

2007